CRDL
Cardiol Therapeutics Inc.
1.08
1 x 0.77
2 x 1.34
bid
ask
+
0.03
3.10%
10:15 AM
timesize
| Ytd | 13.47% | |
| 1y | -22.12% |
1.04
day range
1.09
0.88
52 week range
1.71
| Open | 1.04 | Prev Close | 1.05 | Low | 1.04 | High | 1.09 | Mkt Cap | 124.78M |
| Vol | 59.40K | Avg Vol | 488.00K | EPS | -0.27 | P/E | N/A | Forward P/E | -4.03 |
| Beta | 0.70 | Short Ratio | 1.37 | Inst. Own | 9.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 1.22 | 200-d Avg | 1.11 | 1yr Est | 8.70 |
| Income Statement | |||
| Operating Expenses | 9.71M | ||
| Research and Development Expense | 4.95M | ||
| Selling, General and Administrative Expense | 4.76M | ||
| Operating Income | -9.71M | ||
| Net Income | -10.82M | ||
| Net Income Common Stock | -10.82M | ||
| Net Income Common Stock (USD) | -7.84M | ||
| Consolidated Income | -10.82M | ||
| Earnings per Basic Share | -0.10 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.10 | ||
| Earning Before Interest & Taxes (EBIT) | -10.82M | ||
| Earning Before Interest & Taxes (USD) | -7.84M | ||
| Weighted Average Shares | 108.99M | ||
| Weighted Average Shares Diluted | 108.99M | ||
| Balance Sheet | |||
| Cash and Equivalents | 27.67M | ||
| Cash and Equivalents (USD) | 20.05M | ||
| Trade and Non-Trade Receivables | 339.71K | ||
| Current Assets | 31.27M | ||
| Property, Plant & Equipment Net | 138.97K | ||
| Total Assets | 31.41M | ||
| Debt Current | 39.79K | ||
| Total Debt | 116.41K | ||
| Current Liabilities | 7.13M | ||
| Debt Non-Current | 76.62K | ||
| Total Liabilities | 7.20M | ||
| Accumulated Retained Earnings (Deficit) | -223.89M | ||
| Shareholders Equity | 24.20M | ||
| Shareholders Equity (USD) | 17.54M | ||
| Assets Non-Current | 138.97K | ||
| Total Debt (USD) | 84.35K | ||
| Liabilities Non-Current | 76.62K | ||
| Trade and Non-Trade Payables | 3.42M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 26.71K | ||
| Net Cash Flow from Financing | 13.60M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 6.03M | ||
| Capital Expenditure | -47.58K | ||
| Issuance (Purchase) of Equity Shares | 14.85M | ||
| Issuance (Repayment) of Debt Securities | -13.84K | ||
| Net Cash Flow from Investing | -47.58K | ||
| Net Cash Flow from Operations | -7.52M | ||
| Effect of Exchange Rate Changes on Cash | 221.94K | ||
| Share Based Compensation | 1.84M | ||